Delivery Order SPE2DB24D2205-SPE2DB25FEDMH
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $7,517.54, is a Delivery Order contract for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has an ultimate completion date of April 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-HCTZ 80-25 mg tablets in 30-count units. The $5,254.82 firm fixed-price contract has a performance period extending through May 21, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,621.84, is a delivery order for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has an ultimate completion date of April 15, 2025 and utilizes a firm fixed price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $4,141.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply Telmisartan-HCTZ 80-25 mg tablets. The contract is not a set-aside and is a firm fixed-price arrangement with an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,262.32, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in unit doses of 30s. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit-dose packages of 30, with a ceiling value of $5,020.25. The contract is a firm fixed-price delivery order with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,829.14, is for the delivery of telmisartan-HCTZ 80-25 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,980.67, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in unit dose packages of 30. The contract has an ultimate completion date of April 17, 2025 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,412.35, is for the delivery of telmisartan-HCTZ 80-12.5 mg tablets. This is a firm fixed price delivery order contract with an ultimate completion date of January 29, 2025. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,840.95, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in quantities of 30 per unit. This is a firm-fixed price delivery order contract with a completion date of January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery...